|
1
|
Baade PD, Youlden DR and Krnjacki LJ:
International epidemiology of prostate cancer: geographical
distribution and secular trends. Mol Nutr Food Res. 53:171–184.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Strutz F, Zeisberg M, Ziyadeh FN, et al:
Role of basic fibroblast growth factor-2 in epithelial-mesenchymal
transformation. Kidney Int. 61:1714–1728. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ikenouchi J, Matsuda M, Furuse M and
Tsukita S: Regulation of tight junctions during the
epithelium-mesenchyme transition: direct repression of the gene
expression of claudins/occludin by Snail. J Cell Sci.
116:1959–1967. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jorda M, Olmeda D, Vinyals A, et al:
Upregulation of MMP-9 in MDCK epithelial cell line in response to
expression of the Snail transcription factor. J Cell Sci.
118:3371–3385. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miyoshi A, Kitajima Y, Sumi K, et al:
Snail and SIP1 increase cancer invasion by upregulating MMP family
in hepatocellular carcinoma cells. Br J Cancer. 90:1265–1273. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kovacic JC, Mercader N, Torres M, Boehm M
and Fuster V: Epithelial-to-mesenchymal and
endothelial-to-mesenchymal transition: from cardiovascular
development to disease. Circulation. 125:1795–1808. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kong D, Wang Z, Sarkar SH, et al:
Platelet-derived growth factor-D overexpression contributes to
epithelial-mesenchymal transition of PC3 prostate cancer cells.
Stem Cells. 26:1425–1435. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Valcourt U, Kowanetz M, Niimi H, Heldin CH
and Moustakas A: TGF-beta and the Smad signaling pathway support
transcriptomic reprogramming during epithelial-mesenchymal cell
transition. Mol Biol Cell. 16:1987–2002. 2005. View Article : Google Scholar
|
|
11
|
Todaro GJ, Fryling C and De Larco JE:
Transforming growth factors produced by certain human tumor cells:
polypeptides that interact with epidermal growth factor receptors.
Proc Natl Acad Sci USA. 77:5258–5262. 1980. View Article : Google Scholar
|
|
12
|
Lippman ME: The development of biological
therapies for breast cancer. Science. 259:631–632. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ching KZ, Ramsey E, Pettigrew N, D’Cunha
R, Jason M and Dodd JG: Expression of mRNA for epidermal growth
factor, transforming growth factor-alpha and their receptor in
human prostate tissue and cell lines. Mol Cell Biochem.
126:151–158. 1993. View Article : Google Scholar
|
|
14
|
Glynne-Jones E, Goddard L and Harper ME:
Comparative analysis of mRNA and protein expression for epidermal
growth factor receptor and ligands relative to the proliferative
index in human prostate tissue. Hum Pathol. 27:688–694. 1996.
View Article : Google Scholar
|
|
15
|
Seth D, Shaw K, Jazayeri J and Leedman PJ:
Complex post-transcriptional regulation of EGF-receptor expression
by EGF and TGF-alpha in human prostate cancer cells. Br J Cancer.
80:657–669. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
DeHaan AM, Wolters NM, Keller ET and
Ignatoski KM: EGFR ligand switch in late stage prostate cancer
contributes to changes in cell signaling and bone remodeling.
Prostate. 69:528–537. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Scher HI, Sarkis A, Reuter V, et al:
Changing pattern of expression of the epidermal growth factor
receptor and transforming growth factor alpha in the progression of
prostatic neoplasms. Clin Cancer Res. 1:545–550. 1995.PubMed/NCBI
|
|
18
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma L, Young J, Prabhala H, et al: miR-9, a
MYC/MYCN-activated microRNA, regulates E-cadherin and cancer
metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
20
|
Lin F, Lin P, Zhao D, et al: Sox2 targets
cyclinE, p27 and survivin to regulate androgen-independent human
prostate cancer cell proliferation and apoptosis. Cell Prolif.
45:207–216. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou F, Zhang L, Gong K, et al: LEF-1
activates the transcription of E2F1. Biochem Biophys Res Commun.
365:149–153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou S, Liu Y, Prater K, Zheng Y and Cai
L: Roles of microRNAs in pressure overload- and ischemia-related
myocardial remodeling. Life Sci. 93:855–862. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chang Y, Dou Y, Bao H, et al: Multiple
microRNAs targeted to internal ribosome entry site against
foot-and-mouth disease virus infection in vitro and in vivo. Virol
J. 11:12014. View Article : Google Scholar
|
|
24
|
Luo Q, Wei C, Li X, et al: MicroRNA-195–5p
is a potential diagnostic and therapeutic target for breast cancer.
Oncol Rep. 31:1096–1102. 2014.
|
|
25
|
Lv XB, Jiao Y, Qing Y, et al: miR-124
suppresses multiple steps of breast cancer metastasis by targeting
a cohort of pro-metastatic genes in vitro. Chin J Cancer.
30:821–830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia J, Wu Z, Yu C, et al: miR-124 inhibits
cell proliferation in gastric cancer through down-regulation of
SPHK1. J Pathol. 227:470–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shi XB, Xue L, Ma AH, et al: Tumor
suppressive miR-124 targets androgen receptor and inhibits
proliferation of prostate cancer cells. Oncogene. 32:4130–4138.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gregory PA, Bert AG, Paterson EL, et al:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kumarswamy R, Mudduluru G, Ceppi P, et al:
MicroRNA-30a inhibits epithelial-to-mesenchymal transition by
targeting Snai1 and is downregulated in non-small cell lung cancer.
Int J Cancer. 130:2044–2053. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Martello G, Rosato A, Ferrari F, et al: A
MicroRNA targeting dicer for metastasis control. Cell.
141:1195–1207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liang YJ, Wang QY, Zhou CX, et al: MiR-124
targets Slug to regulate epithelial-mesenchymal transition and
metastasis of breast cancer. Carcinogenesis. 34:713–722. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Eger A, Aigner K, Sonderegger S, et al:
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates
epithelial plasticity in breast cancer cells. Oncogene.
24:2375–2385. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Comijn J, Berx G, Vermassen P, et al: The
two-handed E box binding zinc finger protein SIP1 downregulates
E-cadherin and induces invasion. Mol Cell. 7:1267–1278. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang J, Mani SA, Donaher JL, et al: Twist,
a master regulator of morphogenesis, plays an essential role in
tumor metastasis. Cell. 117:927–939. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cano A, Perez-Moreno MA, Rodrigo I, et al:
The transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hajra KM, Chen DY and Fearon ER: The SLUG
zinc-finger protein represses E-cadherin in breast cancer. Cancer
Res. 62:1613–1618. 2002.PubMed/NCBI
|
|
37
|
Wen FC, Chang TW, Tseng YL, Lee JC and
Chang MC: hRAD9 functions as a tumor suppressor by inducing
p21-dependent senescence and suppressing epithelial-mesenchymal
transition through inhibition of Slug transcription.
Carcinogenesis. Feb 5–2014.(Epub ahead of print).
|
|
38
|
Xia H, Cheung WK, Ng SS, et al: Loss of
brain-enriched miR-124 microRNA enhances stem-like traits and
invasiveness of glioma cells. J Biol Chem. 287:9962–9971. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tamagawa S, Beder LB, Hotomi M, et al:
Role of miR-200c/miR-141 in the regulation of
epithelial-mesenchymal transition and migration in head and neck
squamous cell carcinoma. Int J Mol Med. 33:879–886. 2014.PubMed/NCBI
|
